Structures by: Janiak C.
Total: 309
C27H27NO3
C27H27NO3
Journal of natural products (2019) 82, 6 1412-1423
a=11.8611(5)Å b=7.1874(3)Å c=24.2244(10)Å
α=90° β=94.4960(10)° γ=90°
Rhinomilisin C
2(C16H25ClO6),3(H2O)
Journal of natural products (2019) 82, 5 1055-1062
a=18.0154(15)Å b=6.3425(5)Å c=16.3801(13)Å
α=90° β=103.812(5)° γ=90°
Pestalotioprolide C
C14H24O4
Journal of natural products (2016) 79, 9 2332-2340
a=36.533(4)Å b=4.9693(6)Å c=7.6479(9)Å
α=90° β=90° γ=90°
Nigrosporolide
C14H20O4
Journal of natural products (2016) 79, 9 2332-2340
a=4.8042(3)Å b=7.6036(4)Å c=37.247(2)Å
α=90° β=90° γ=90°
Pestalotioprolide B hydrate
C14H20O5,H2O
Journal of natural products (2016) 79, 9 2332-2340
a=6.3082(4)Å b=7.5108(5)Å c=8.1100(5)Å
α=88.911(4)° β=85.044(4)° γ=77.888(5)°
Chlorido-(N,N-dimethyl(4-fluoro)benzylamine- κN,κC)(dimethylsulfoxide-κS)platinum(II)
C11H17ClFNOPtS
Journal of medicinal chemistry (2015) 58, 3 1320-1336
a=5.9315(3)Å b=12.1005(5)Å c=19.7000(8)Å
α=90.00° β=103.0670(10)° γ=90.00°
Chlorido-(N,N-dimethyl(4-methoxy)benzylamine- κN,κC)-tris(4-trifluoromethylphenyl)phosphane-platinum(II)
C31H26ClF9NOPPt
Journal of medicinal chemistry (2015) 58, 3 1320-1336
a=17.3951(8)Å b=14.9557(7)Å c=11.9109(5)Å
α=90.00° β=98.576(2)° γ=90.00°
C45H33Mn3N3O13S6,C2H3N
C45H33Mn3N3O13S6,C2H3N
Inorganica Chimica Acta (2013) 401, 85-94
a=19.1258(9)Å b=23.0759(12)Å c=23.5440(12)Å
α=90.00° β=90.00° γ=90.00°
C45H33Mn3N3O13S6,O
C45H33Mn3N3O13S6,O
Inorganica Chimica Acta (2013) 401, 85-94
a=18.974(4)Å b=22.931(5)Å c=23.640(5)Å
α=90.00° β=90.00° γ=90.00°
C47H33Mn4O21S9,C16H36N,C5H4O2S,CH2Cl2
C47H33Mn4O21S9,C16H36N,C5H4O2S,CH2Cl2
Inorganica Chimica Acta (2013) 401, 85-94
a=14.723(3)Å b=20.353(4)Å c=28.020(6)Å
α=90.00° β=92.77(3)° γ=90.00°
C81H81Mn4O20,C16H36N,CH2Cl2
C81H81Mn4O20,C16H36N,CH2Cl2
Inorganica Chimica Acta (2013) 401, 85-94
a=16.5930(13)Å b=27.958(3)Å c=22.7744(17)Å
α=90.00° β=108.246(4)° γ=90.00°
Chlorido-(1-methyl-4-isopropyl-benzene)- (N-n-butyl-(para-trifluoromethylphenyl)(methylester)benzimidazol-κN,C)ruthenium(II)
C30H32ClF3N2O2Ru
Journal of medicinal chemistry (2015) 58, 18 7310-7327
a=12.5656(6)Å b=17.1429(8)Å c=13.9971(7)Å
α=90.00° β=108.785(2)° γ=90.00°
Chlorido-(pentamethylcyclopentadienyl)- (N-n-butyl-(para-trifluoromethylphenyl)(methylester)benzimidazol-κN,C)iridium(II)
C30H33ClF3IrN2O2
Journal of medicinal chemistry (2015) 58, 18 7310-7327
a=11.3662(9)Å b=17.1523(13)Å c=15.5280(15)Å
α=90.00° β=111.111(2)° γ=90.00°
Chrysosplentin
C19H18O8
RSC Advances (2020) 10, 62 38128-38141
a=7.2577(3)Å b=17.3639(8)Å c=13.3620(6)Å
α=90° β=95.789(2)° γ=90°
C84H127N16O17PS
C84H127N16O17PS
CrystEngComm (2020)
a=13.8359(11)Å b=18.7145(15)Å c=19.6641(15)Å
α=104.991(2)° β=99.589(3)° γ=104.672(2)°
C52H57N13O14S2
C52H57N13O14S2
CrystEngComm (2020)
a=9.4857(4)Å b=17.0599(7)Å c=18.6326(8)Å
α=64.282(2)° β=80.544(2)° γ=87.541(2)°
C8H7O5.50P1.25Zn,CH2
C8H7O5.50P1.25Zn,CH2
CrystEngComm (2020)
a=21.4445(11)Å b=21.4445(11)Å c=9.3118(5)Å
α=90° β=90° γ=90°
2(C10.50H12N0.50O5PZn),2(C4H9NO)
2(C10.50H12N0.50O5PZn),2(C4H9NO)
CrystEngComm (2020)
a=19.912(4)Å b=19.912(4)Å c=9.5338(17)Å
α=90° β=90° γ=90°
Ce-HHU-1
C66.24Ce24O144.64
Dalton transactions (Cambridge, England : 2003) (2019) 48, 42 15849-15855
a=19.1733(5)Å b=19.1733(5)Å c=19.1733(5)Å
α=90° β=90° γ=90°
C24H22CuN4O4,C3H7NO
C24H22CuN4O4,C3H7NO
Dalton transactions (Cambridge, England : 2003) (2020) 49, 36 12854-12864
a=10.0436(8)Å b=17.2646(14)Å c=17.3187(14)Å
α=90° β=105.201(4)° γ=90°
C24H22CuN4O4,8.968(H2O)
C24H22CuN4O4,8.968(H2O)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 36 12854-12864
a=23.2432(12)Å b=23.2432(12)Å c=11.9130(7)Å
α=90° β=90° γ=90°
C24H22CuN4O4,2(C2H3N)
C24H22CuN4O4,2(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 36 12854-12864
a=9.7946(10)Å b=19.5794(17)Å c=14.8975(14)Å
α=90° β=103.587(5)° γ=90°
C30H24Cl4CuN2O2
C30H24Cl4CuN2O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8247-8264
a=13.976(3)Å b=10.721(2)Å c=10.339(2)Å
α=90° β=118.05(3)° γ=90°
C30H24Br4CuN2O2
C30H24Br4CuN2O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8247-8264
a=10.427(2)Å b=10.778(2)Å c=13.058(3)Å
α=90° β=106.74(3)° γ=90°
C30H24Br4CuN2O2
C30H24Br4CuN2O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8247-8264
a=14.1169(5)Å b=10.7071(4)Å c=10.3296(4)Å
α=90° β=117.7800(10)° γ=90°
C30H24Br2Cl2CuN2O2
C30H24Br2Cl2CuN2O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8247-8264
a=10.33616(17)Å b=10.64041(15)Å c=13.0212(2)Å
α=90° β=107.5551(17)° γ=90°
C30H24Br2Cl2CuN2O2
C30H24Br2Cl2CuN2O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8247-8264
a=14.040(3)Å b=10.708(2)Å c=10.439(2)Å
α=90° β=117.772(3)° γ=90°
C30H24CuI4N2O2
C30H24CuI4N2O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8247-8264
a=14.5549(3)Å b=11.1475(3)Å c=10.6074(3)Å
α=90° β=118.1800(10)° γ=90°
C30H24CuI4N2O2
C30H24CuI4N2O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8247-8264
a=14.5586(3)Å b=11.1467(2)Å c=10.6165(2)Å
α=90° β=118.2090(10)° γ=90°
C30H24Cl4CuN2O2
C30H24Cl4CuN2O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8247-8264
a=8.57142(6)Å b=14.70541(11)Å c=11.09232(8)Å
α=90° β=97.2834(7)° γ=90°
C30H24Cl4CuN2O2
C30H24Cl4CuN2O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 24 8247-8264
a=8.6322(2)Å b=14.8439(3)Å c=11.1572(3)Å
α=90° β=97.8710(10)° γ=90°
C19H24CuN6O6
C19H24CuN6O6
Dalton transactions (Cambridge, England : 2003) (2019) 48, 23 8057-8067
a=12.7515(16)Å b=12.8834(16)Å c=13.5198(16)Å
α=90° β=107.355(7)° γ=90°
[Cu (N O3)2 (C10 H10 N4)]
Cu,2(NO3),(C10H10N4)
Journal of the Chemical Society, Dalton Transactions (1999) 17 3121
a=6.111(8)Å b=7.445(8)Å c=9.335(8)Å
α=82.29(8)° β=83.07(8)° γ=67.23(8)°
[(dmbp)Cu2I2]
(C10H10N4),Cu2,I2
Journal of the Chemical Society, Dalton Transactions (1999) 17 3121
a=7.7509(12)Å b=10.5927(18)Å c=4.2001(7)Å
α=91.81(2)° β=101.993(18)° γ=88.544(19)°
[(dmbp)(H2O)NiCl2] . CH3NO2
(C10H10N4),Cl2,Ni,(CH3NO2),(H2O)
Journal of the Chemical Society, Dalton Transactions (1999) 17 3121
a=13.506(3)Å b=7.6665(10)Å c=15.374(3)Å
α=90.00° β=100.69(2)° γ=90.00°
2,2'-dimethyl-4,4'-bipyrimidine.CuI
(C10H10N4),CuI
Journal of the Chemical Society, Dalton Transactions (1999) 17 3121
a=33.463(2)Å b=35.0765(18)Å c=4.0449(2)Å
α=90.00° β=90.00° γ=90.00°
[(C10 H10 N4)2 Ag3](BF4)3 . 3 CH3CN
2(C10H10N4),3Ag,3(BF4),3(C2H3N)
Journal of the Chemical Society, Dalton Transactions (1999) 17 3121
a=17.1706(11)Å b=10.8107(7)Å c=21.3415(13)Å
α=90.00° β=109.697(7)° γ=90.00°
[Ag3 (N O3)3 (C10 H10 N4)2]
3Ag,3(NO3),2(C10H10N4)
Journal of the Chemical Society, Dalton Transactions (1999) 17 3121
a=7.068(8)Å b=21.811(15)Å c=19.408(15)Å
α=90.00° β=90.00° γ=90.00°
[(C10 H10 N4)2 Ag3](PF6)3 . 3 CH3CN
2(C10H10N4),3Ag,3(PF6),3(C2H3N)
Journal of the Chemical Society, Dalton Transactions (1999) 17 3121
a=17.3846(11)Å b=10.9689(10)Å c=21.9716(14)Å
α=90.00° β=105.148(7)° γ=90.00°
Bis(2-phenyl-1H-benzo[d]imidazole-κ^2^N,C)-{methyl 1-butyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxylate-κ^2^N,N}iridium(III) hexafluorophosphate tris(dichloromethane) solvate
C44H37IrN7O2,F6P,3(CH2Cl2)
Chemical communications (Cambridge, England) (2016) 52, 98 14165-14168
a=22.1254(11)Å b=16.4448(9)Å c=28.2843(15)Å
α=90° β=90° γ=90°
Bis(1-phenyl-1H-pyrazole-κ^2^N,C)-{methyl 1-butyl-2-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxylate-κ^2^N,N}iridium(III) hexafluorophosphate dichloromethane solvate
C35H29.50IrN7O2,F6P,0.5(CH2Cl2)
Chemical communications (Cambridge, England) (2016) 52, 98 14165-14168
a=24.4157(10)Å b=16.5559(7)Å c=23.3462(9)Å
α=90° β=113.7896(14)° γ=90°
Chlorido-(1-methyl-4-isopropyl-benzene)-(N-n-butyl-(phenyl)(methylester)benzimidazol-κN,C)osmium(II)
C29H33ClN2O2Os
Chemical communications (Cambridge, England) (2018) 54, 79 11120-11123
a=11.0472(6)Å b=19.7668(10)Å c=12.2934(6)Å
α=90° β=113.1612(18)° γ=90°
Acetato-(1-methyl-4-isopropyl-benzene)-(N-n-butyl-(4-biphenyl)(methylester)benzimidazol-κN,C)osmium(II)hemi-dichloromethane, hemi-toluene solvate
C37H40N2O4Os,0.5(C7H8),0.5(CH2Cl2)
Chemical communications (Cambridge, England) (2018) 54, 79 11120-11123
a=10.9559(6)Å b=10.9932(6)Å c=16.2594(9)Å
α=105.966(2)° β=102.536(2)° γ=103.578(2)°
C26H34N4O2PbSe2
C26H34N4O2PbSe2
New Journal of Chemistry (2020) 44, 19 7719-7726
a=20.7267(5)Å b=13.0349(11)Å c=10.1701(2)Å
α=90° β=90° γ=90°
C16H23ClN2OSe
C16H23ClN2OSe
New Journal of Chemistry (2020) 44, 19 7719-7726
a=10.6871(5)Å b=15.8440(6)Å c=10.4873(4)Å
α=90° β=103.813(4)° γ=90°
C32H28N6O6PbSe2
C32H28N6O6PbSe2
New Journal of Chemistry (2020) 44, 19 7719-7726
a=14.1737(2)Å b=14.1942(2)Å c=16.5168(2)Å
α=90° β=95.0944(16)° γ=90°
C16H23ClN2OSe
C16H23ClN2OSe
New Journal of Chemistry (2020) 44, 19 7719-7726
a=8.1942(7)Å b=10.8431(8)Å c=11.8118(12)Å
α=64.775(8)° β=69.712(8)° γ=80.596(6)°
C32H44Cl2N4O2PbSe2
C32H44Cl2N4O2PbSe2
New Journal of Chemistry (2020) 44, 19 7719-7726
a=17.9384(5)Å b=19.0184(12)Å c=10.4156(4)Å
α=90° β=90° γ=90°
C40H26N4O12S2Zn2
C40H26N4O12S2Zn2
New Journal of Chemistry (2018) 42, 22 18152
a=11.7927(10)Å b=12.7479(11)Å c=17.1763(16)Å
α=103.520(4)° β=105.261(4)° γ=97.511(4)°
C26H21N2O6P
C26H21N2O6P
New Journal of Chemistry (2006)
a=28.659(5)Å b=6.8903(12)Å c=24.209(4)Å
α=90.00° β=113.548(3)° γ=90.00°
C26H18NO6P
C26H18NO6P
New Journal of Chemistry (2006)
a=6.8200(11)Å b=12.3523(19)Å c=25.480(4)Å
α=90.00° β=90.00° γ=90.00°
C43H48N6O13P2
C43H48N6O13P2
New Journal of Chemistry (2006)
a=10.0813(15)Å b=11.2429(17)Å c=21.107(3)Å
α=93.363(3)° β=98.274(3)° γ=112.770(3)°
C46H54CuO17P2
C46H54CuO17P2
New Journal of Chemistry (2006)
a=41.876(6)Å b=8.6579(13)Å c=13.225(2)Å
α=90.00° β=105.860(3)° γ=90.00°
C46H56N4NiO14P2
C46H56N4NiO14P2
New Journal of Chemistry (2006)
a=42.5440(18)Å b=9.0870(4)Å c=12.3730(5)Å
α=90.00° β=98.7550(19)° γ=90.00°
C46H56N4NiO14P2
C46H56N4NiO14P2
New Journal of Chemistry (2006)
a=42.599(8)Å b=9.0906(18)Å c=12.432(2)Å
α=90.00° β=98.762(4)° γ=90.00°
C43.5H54.5CuN4O14P2
C43.5H54.5CuN4O14P2
New Journal of Chemistry (2006)
a=20.867(2)Å b=9.1006(11)Å c=12.2266(14)Å
α=90.00° β=97.654(2)° γ=90.00°
Tetrakis(μ-amino-ethanolato-κN,O:O)-dibromido-tricopper(II)
C8H24Br2Cu3N4O4
New Journal of Chemistry (2012) 36, 8 1596
a=8.7424(2)Å b=8.9246(2)Å c=11.6251(3)Å
α=90.00° β=108.5920(10)° γ=90.00°
Tetrakis(μ-(R)-2-amino-butan-1-olato-κN,O:O)-dibromido-tricopper(II)
C16H40Br2Cu3N4O4
New Journal of Chemistry (2012) 36, 8 1596
a=9.0782(18)Å b=11.603(2)Å c=12.489(3)Å
α=102.76(3)° β=100.94(3)° γ=90.00(3)°
Bis(bis(mu-(R)-2-amino-butan-1-olato-kappaN,O:O)-dibromido- dicopper(ii))-(bis((R)-2-amino-butan-1-ol-kappaN,O)-dibromido- copper(ii))-(((R)-2-amino-butan-1-ol-kappaN,O)-dibromido-methanol- copper(ii))
C29H77Br8Cu6N7O8
New Journal of Chemistry (2012) 36, 8 1596
a=10.2700(17)Å b=12.8186(16)Å c=20.588(3)Å
α=90.00° β=93.281(8)° γ=90.00°
Bis[bis(μ-(R)-2-amino-butan-1-olato-κN,O:O)-dibromido-dicopper(II)]- bis[((R)-2-amino-butan-1-ol-κN,O)-dibromido-ethanol-copper(II)]
C28H74Cl8Cu6N6O8
New Journal of Chemistry (2012) 36, 8 1596
a=10.3649(3)Å b=12.7064(3)Å c=19.3781(5)Å
α=90.00° β=92.255(2)° γ=90.00°
Bis[rac-(2-amino-butan-1-olato-κN,O)-rac-(2-amino-butan-1-ol-κN,O)-aqua- copper(II)] di-perchlorate
C16H46Cl2Cu2N4O14
New Journal of Chemistry (2012) 36, 8 1596
a=16.2260(3)Å b=16.2256(3)Å c=5.60100(10)Å
α=90.00° β=90.00° γ=90.00°
HHU-1
C18H18Co4N6O7
CrystEngComm (2013) 15, 45 9757
a=20.1090(7)Å b=20.1090(7)Å c=20.1090(7)Å
α=90.00° β=90.00° γ=90.00°
HHU-2
C18H18N6O7Zn4
CrystEngComm (2013) 15, 45 9757
a=20.071(3)Å b=20.071(3)Å c=20.071(3)Å
α=90.00° β=90.00° γ=90.00°
HHU-3
C36H20Co4N6O7
CrystEngComm (2013) 15, 45 9757
a=14.242(3)Å b=14.278(3)Å c=14.332(4)Å
α=90.00° β=90.00° γ=90.00°
4(C36H18O13Zn4),4(C3H7NO),4(C5H9NO),13(H2O)
4(C36H18O13Zn4),4(C3H7NO),4(C5H9NO),13(H2O)
J. Mater. Chem. A (2014) 2, 44 18823
a=30.5557(17)Å b=30.5557(17)Å c=30.5557(17)Å
α=90.00° β=90.00° γ=90.00°
C15H12NO4Zn
C15H12NO4Zn
J. Mater. Chem. A (2014) 2, 44 18823
a=16.052(5)Å b=21.172(5)Å c=9.625(5)Å
α=90.000(5)° β=90.000(5)° γ=90.000(5)°
Aculeatine A
C21H22N2O4,CH4O
RSC Advances (2018) 8, 14 7863
a=23.52(2)Å b=5.994(5)Å c=15.843(13)Å
α=90° β=112.574(17)° γ=90°
Henicosa-[μ~3~-oxido]-nonadeca-[μ~3~-hydroxido]-octa-[μ-hydroxido]-tetraicosa-[μ-formiato-κ^2^O1:O2]-tetra-[formiato-κ^2^O1:O2]-hepta-[formiato-κO]-pentaaqua-hexaicosazirconium(IV) penta-formic acid solvate pentadecahydrate
C35H72O123Zr26,5(CH2O2)[solvent]
CrystEngComm (2018) 20, 35 5132
a=11.4132(8)Å b=18.7392(12)Å c=19.1989(11)Å
α=71.434(5)° β=73.347(5)° γ=81.818(5)°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.9154(8)Å b=9.9154(8)Å c=21.343(2)Å
α=90.00° β=90.00° γ=90.00°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn1
CrystEngComm (2018) 20, 33 4724
a=9.9138(3)Å b=9.9138(3)Å c=21.3276(8)Å
α=90.00° β=90.00° γ=90.00°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn1
CrystEngComm (2018) 20, 33 4724
a=9.9041(3)Å b=9.9041(3)Å c=21.3545(7)Å
α=90.00° β=90.00° γ=90.00°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.8663(6)Å b=9.8663(6)Å c=21.1146(17)Å
α=90° β=90° γ=90°
Δ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn1
CrystEngComm (2018) 20, 33 4724
a=9.9077(12)Å b=9.9077(12)Å c=21.330(3)Å
α=90.00° β=90.00° γ=90.00°
Λ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.8592(4)Å b=9.8592(4)Å c=21.1220(10)Å
α=90° β=90° γ=90°
Δ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.8258(19)Å b=9.8258(19)Å c=21.005(5)Å
α=90.00° β=90.00° γ=90.00°
Δ-bis[N-2-(pyridyl)salicylaldiminato-κ^2^N,O]zinc(II)
C24H18N4O2Zn
CrystEngComm (2018) 20, 33 4724
a=9.8329(12)Å b=9.8329(12)Å c=21.061(2)Å
α=90.00° β=90.00° γ=90.00°
Catena-(dodecakis(μ~3~-4,5-diamide-2-olato-imidazolato)-(μ-~6~oxo)-tetra- aqua-dihydroxo-tetradeca-zinc(II)) dimethylformamide solvate
C8.5H8.25Co1.75N6.5O5.375,2(C3H7NO)
Chem.Commun. (2014) 50, 5441
a=17.8029(3)Å b=17.8029(3)Å c=29.2271(7)Å
α=90° β=90° γ=90°
(Tris(N,N'-(2,2')bipyridinyl-5,5'-diyl-bis-carbamic acid diethyl ester)iron(ii))-diperchlorate - di- ethanol'
(C16H18N4O4)3Fe,(NO3)2,(C2H6O)2
Chemical Communications (Cambridge, United Kingdom) (2003) 7 902-903
a=18.49(6)Å b=24.91(8)Å c=15.14(5)Å
α=90.00° β=117.69(5)° γ=90.00°
(Tris(N,N'-(2,2')bipyridinyl-5,5'-diyl-bis-carbamic acid diethyl ester)iron(ii))-sulfate- hemi-methanol - 3.2 water
(C16H18N4O4)3Fe,S1O4,(C1H4O1)0.5,(H2O)3.2
Chemical Communications (Cambridge, United Kingdom) (2003) 7 902-903
a=14.0449(10)Å b=22.8722(16)Å c=18.8110(13)Å
α=90.00° β=100.8330(10)° γ=90.00°
(Tris(N,N'-(2,2')bipyridinyl-5,5'-diyl-bis-carbamic acid diethyl ester)iron(ii))-diperchlorate- dihydrate
(C16H18N4O4)3Fe,(ClO4)2,(H2O)2
Chemical Communications (Cambridge, United Kingdom) (2003) 7 902-903
a=18.459(5)Å b=25.212(6)Å c=14.755(4)Å
α=90.00° β=117.340(4)° γ=90.00°
(η^5^pentamethylcyclopentadienyl)- (methyl 1-butyl-2-phenyl-benzimidazole carboxylate-κC,N)- chlorido-iridium(III)
C29H34ClIrN2O2
Chem.Commun. (2013) 49, 11533
a=12.1557(7)Å b=14.0158(8)Å c=15.6731(9)Å
α=90.00° β=90.00° γ=90.00°
Catena-(dodecakis(μ~3~-4,5-diamide-2-olato-imidazolato)-(μ-~6~oxo)-tetra- aqua-dihydroxo-tetradeca-zinc(II)) dimethylformamide solvate
C8.5H8.25Co1.75N6.5O5.375,2(C3H7NO)
Chemical communications (Cambridge, England) (2014) 50, 41 5441-5443
a=17.8029(3)Å b=17.8029(3)Å c=29.2271(7)Å
α=90° β=90° γ=90°
Co-BNP-KSCN, Nr. 2943
2(C16N4H10),2(SCN),Co
Chemical Communications (1998) 23 2637
a=21.4385(17)Å b=15.9180(10)Å c=8.3683(5)Å
α=90.00° β=90.00° γ=90.00°
Zn-BNP-KSCN, Nr. 0751
2(C16N4H10),2(SCN),Zn
Chemical Communications (1998) 23 2637
a=21.5003(19)Å b=15.9253(10)Å c=8.3967(5)Å
α=90° β=90° γ=90°
Cd_BNP_KSCN_2941
2(C16N4H10),2(SCN),Cd
Chemical Communications (1998) 23 2637
a=21.9537(13)Å b=16.0270(11)Å c=8.5477(6)Å
α=90.00° β=90.00° γ=90.00°
Cu-BNP-CH3CN-BF4, Nr. 0946
BF4,0.5(CH2Cl2),Cu,C16N4H10,C2H3N
Chemical Communications (1998) 23 2637
a=22.4063(16)Å b=8.1045(4)Å c=22.5896(18)Å
α=90.00° β=100.771(9)° γ=90.00°
C104H100Cd2N8O13.63V2
C104H100Cd2N8O13.63V2
Chemical communications (Cambridge, England) (2016) 52, 7 1401-1404
a=17.0460(5)Å b=24.0462(6)Å c=28.8442(6)Å
α=90° β=90° γ=90°
Catena-clambda-(triaqua-1.5(mu-dihydroxymalonato- kappaO,O'':O''',O'''')lanthanum(iii))
C9H18La2O24
Chemical communications (Cambridge, England) (2010) 46, 43 8270-8272
a=9.75040(10)Å b=9.75040(10)Å c=21.2854(15)Å
α=90.00° β=90.00° γ=120.00°
Catena-clambda-(triaqua-1.5(mu-dihydroxymalonato- kappaO,O'':O''',O'''')gadolinium(iii))
C9H18Gd2O24
Chemical communications (Cambridge, England) (2010) 46, 43 8270-8272
a=9.6396(8)Å b=9.6396(8)Å c=20.7433(16)Å
α=90.00° β=90.00° γ=120.00°
Bis((N,N-dimethylbenzylamine-kappaN,kappaC)palladium(ii))(mu- acetato-kappaO:kappaO') (mu-benzophenone iminato-kappaN:kappaN) . 1.5benzene
C33H37N3O2Pd2,0.5(C12H12),0.5(C6H6)
CrystEngComm (2008) 10, 12 1928
a=9.3712(5)Å b=11.2535(7)Å c=18.6983(11)Å
α=83.304(3)° β=84.253(3)° γ=78.682(3)°
[{(dmba)Pd}2(m-OAc)(m-N=CPh2)].1(n-hexane)
C33H37N3O2Pd2,C6H14
CrystEngComm (2008) 10, 12 1928
a=14.2859(6)Å b=28.3485(12)Å c=9.2862(4)Å
α=90.00° β=103.8940(10)° γ=90.00°
Bis((N,N-dimethylbenzylamine-kappaN,kappaC)palladium(ii))(mu- acetato-kappaO:kappaO') (mu-benzophenone iminato-kappaN:kappaN) . 1.5toluene
C33H37N3O2Pd2,1.5(C7H8)
CrystEngComm (2008) 10, 12 1928
a=9.5075(5)Å b=11.3472(6)Å c=18.5747(10)Å
α=82.7420(10)° β=83.1070(10)° γ=75.9870(10)°
Bis((N,N-dimethylbenzylamine-kappaN,kappaC)palladium(ii))(mu- acetato-kappaO:kappaO') (mu-benzophenone iminato-kappaN:kappaN) . !0.25toluene
2(C33H37N3O2Pd2),0.5(C7)
CrystEngComm (2008) 10, 12 1928
a=10.2650(10)Å b=18.6510(10)Å c=18.2170(10)Å
α=78.708(5)° β=81.334(5)° γ=75.924(5)°
Η^5^-cyclopentadienyl(pentafluorophenyl)(triphenylphosphane)palladium(II)
[Pd(η^5^C5H5)(C6F5){P(C6H5)3}]
CrystEngComm (2006) 8, 9 662-665
a=15.1813(6)Å b=17.6908(7)Å c=35.4575(14)Å
α=90.00° β=90.00° γ=90.00°
Ammonium-(aqua(μ3-hydroxo)bis(μ4-phosphato)diferrate(iii))-hydrate
Fe2,(PO4)2,OH,NH4,(H2O)2
CrystEngComm (2003) 5, 33 180
a=9.815(2)Å b=9.7225(19)Å c=9.877(2)Å
α=90.00° β=102.87(3)° γ=90.00°
H2piperazinedium-(aqua)(μ3-hydrogenphosphato)(tris-μ4-phosphato)- tri-iron(iii)-0.25hydrate
3Fe,(C4N2H12),3(PO4),HPO4,1.25H2O
CrystEngComm (2003) 5, 33 180
a=6.3554(16)Å b=9.166(2)Å c=15.311(4)Å
α=90.270(4)° β=91.338(4)° γ=106.594(4)°
Hexaaquairon(ii)-H2piperazinedium-bis(hydrogenphosphate)
Fe(H2O)6,C4H12N2,2(HPO4)
CrystEngComm (2003) 5, 33 180
a=6.317(4)Å b=9.643(5)Å c=12.877(7)Å
α=90.00° β=92.574(9)° γ=90.00°
Tris(aqua-ethanol-di(mu4-terephthaloyl-bis(L- phenylalaninato))dicopper(ii)) hydrate
C163H156Cu6N12O58.38,3(O2.98),1.11(O),0.69(O),0.72(O)
CrystEngComm (2008) 10, 5 461
a=39.7978(3)Å b=39.7978(3)Å c=10.1735(2)Å
α=90.00° β=90.00° γ=120.00°
(tetraammine-kappa$2!O,O'-((S)-1,1'-bi-2-naphtholate(2- ))cadmium(ii))-bis((S)-1,1'-bi-2-naphthol)hydrate-bis(methanol)
[Cd(C20H12O2)(NH3)4],2(C20H14O2),H2O,2(CH3OH)
CrystEngComm (2005) 7, 51 309
a=24.024(6)Å b=10.689(2)Å c=10.982(2)Å
α=90.00° β=108.657(4)° γ=90.00°